TI
XERS icon

Tidal Investments’s Xeris Biopharma Holdings XERS Stock Holding History

Tidal Investments’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Buy
+18,159
New +$120K ﹤0.01% 2263
2025
Q4 		– Sell
-19,485
Closed -$159K – 2380
2025
Q3 		$159K Buy
+19,485
New +$129K ﹤0.01% 1961

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tidal Investments's XERS Position: Q1 2026 in Review

Tidal Investments opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 18,159 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #2263 among its holdings. This is a return to the name: Tidal Investments previously reported a position in XERS as recently as Q3 2025.

Tidal Investments first reported a position in XERS in Q3 2025 and has held it in 2 quarters since. The position peaked at $159K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Tidal Investments held 18,159 shares of Xeris Biopharma Holdings worth $105K as of Q1 2026.
  • Xeris Biopharma Holdings was a new Tidal Investments position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #2263 holding.
  • Tidal Investments first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 2 quarters since.
  • Tidal Investments's Xeris Biopharma Holdings position peaked at $159K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.